Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J5DC
|
|||
| Former ID |
DAP000262
|
|||
| Drug Name |
Clofibrate
|
|||
| Synonyms |
Amotril; Angiokapsul; Anparton; Antilipid; Antilipide; Apolan; Arterioflexin; Arterosol; Artevil; Ateculon; Ateriosan; Athebrate; Atheromide; Atheropront; Athromidin; Atrolen; Atromid; Atromida; Atromidin; Atrovis; Azionyl; Bioscleran; Bresit; CPIB; Cartagyl; Chlorfenisate; Chlorphenisate; Cinnarizin; Citiflus; Claripex; Cloberat; Clobrat; Clofar; Clofibate; Clofibram; Clofibrat; Clofibrato; Clofibratum; Clofinit; Clofipront; Delipid; Deliva; ELPI; EPIB; Fibralem; Gerastop; Hyclorate; Klofibrat; Klofiran; Levatrom; Lipamid; Lipavil; Lipavlon; Lipidsenker; Lipofacton; Lipomid; Liponorm; Liporeduct; Liporil; Liposid; Liprin; Liprinal; Lobetrin; Miscleron; Misclerone; Miskleron; Negalip; Normalip; Normat; Normet; Normolipol; Novofibrate; Persantinat; Recolip; Regardin; Regelan; Robigram; Scrobin; Serofinex; Serotinex; Skerolip; Sklerepmexe; Sklero; Sklerolip; Skleromex; Skleromexe; Ticlobran; Xyduril; Yoclo; Amotril S; Atromid S; Claripex CPIB; Clofibrato [Spanish]; Dura clofibrat; Ethyl chlorophenoxyisobutyrate; Ethyl clofibrate; Regelan N; Vincamin compositum; AY 61123; C 6643; Lipide 500; Oxan 600; AY-61123; Athranid-wirkstoff; Atromid-S; BML2-F02; Chlorophenoxyisobutyrate, Ethyl; Clobren-5F; Clobren-SF; Clofibrate (CLOF); Clofibrato [INN-Spanish]; Clofibratum [INN-Latin]; Clofibric Acid, Ethyl Ester; Ethyl p-chlorophenoxyisobutyrate; Ethyl para-chlorophenoxyisobutyrate; Neo-Atomid; Neo-Atromid; Sklero-Tablinen; Sklero-tablinene; Sklero-tabuls; ATROMID-S (TN); Atromid-S (TN); Atromid-S, Clofibrate; Ethyl alpha-p-chlorophenoxyisobutyrate; Clofibrate (JP15/USP/INN); Clofibrate [USAN:INN:BAN:JAN]; Ethyl 2-(4-chlorophenoxy)isobutyrate; Ethyl 2-(p-chlorophenoxy)isobutyrate; Ethyl alpha-(4-chlorophenoxy)isobutyrate; Ethyl alpha-(p-chlorophenoxy)isobutyrate; Ethyl-alpha-p-chlorophenoxy-isobutyrate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Dysbetalipoproteinemia [ICD-11: 5C80.2; ICD-10: E78.2; ICD-9: 272.2] | Approved | [1], [2] | |
| Therapeutic Class |
Antilipemic Agents
|
|||
| Company |
Ayerst Laboratories Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H15ClO3
|
|||
| Canonical SMILES |
CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl
|
|||
| InChI |
1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3
|
|||
| InChIKey |
KNHUKKLJHYUCFP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 637-07-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9133, 119396, 221613, 893268, 3218686, 4302581, 7847345, 7978969, 8147031, 8149997, 8150180, 8151805, 10531332, 10852042, 11110971, 11120027, 11120515, 11121003, 11121642, 11122122, 11147110, 11335997, 11336101, 11361236, 11361340, 11362711, 11364629, 11365273, 11367191, 11367835, 11369753, 11370693, 11370694, 11373436, 11374024, 11375997, 11377915, 11446100, 11452212, 11462208, 11462312, 11484734, 11489025, 11492038, 11495549, 14798427, 17404869, 22391427, 22395216, 24278085
|
|||
| ChEBI ID |
CHEBI:3750
|
|||
| SuperDrug ATC ID |
C10AB01
|
|||
| SuperDrug CAS ID |
cas=000637070
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2667). | |||
| REF 2 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 070531. | |||
| REF 3 | Effects of clofibrate treatment in laying hens. Poult Sci. 2007 Jun;86(6):1187-95. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.